Form 4: Cyanotech CEO Granted Significant Equity Compensation Package
Insider Transaction Report
Cyanotech Corp. has granted its President and CEO, Matthew Keith Custer, a substantial equity compensation package comprising stock options and restricted stock units, effective June 16, 2025.
Summary
- Matthew Keith Custer, President and CEO, Director, and 10% Owner of Cyanotech Corp. (CYAN), was granted new equity compensation.
- The grant, effective June 16, 2025, includes 150,000 stock options with an exercise price of $0.39 per share and an expiration date of June 16, 2035.
- These stock options will vest in three equal annual installments of 50,000 shares on June 16, 2026, June 16, 2027, and June 16, 2028, contingent on continued service with Cyanotech.
- Additionally, Mr. Custer acquired 64,103 Restricted Stock Units (RSUs), each representing the contingent right to receive one share of Cyanotech Common Stock.
- The RSUs will vest in three annual installments: 21,368 shares on June 16, 2026; 21,368 shares on June 16, 2027; and 21,367 shares on June 16, 2028, also subject to continued service with the Company.
- Following these reported transactions, Mr. Custer's beneficial ownership of derivative securities is reported as 150,000 stock options and 4,679 Restricted Stock Units.
Sentiment
Score: 7
Explanation: The grant of equity compensation to the CEO is generally a positive sign for leadership retention and alignment of interests, though it carries a minor potential for future dilution. It's a standard corporate action.
Positives
- The grant of stock options and restricted stock units aligns the interests of the President and CEO, Matthew Keith Custer, with those of shareholders, incentivizing long-term performance and retention.
- The vesting schedule, tied to continued service over three years, promotes stability in leadership and encourages long-term commitment from the executive.
Negatives
- The issuance of new equity compensation, particularly stock options and RSUs, can lead to potential future dilution for existing shareholders when these awards vest and are exercised or converted into common stock.
Risks
- The vesting of both the 150,000 stock options and the 64,103 restricted stock units is contingent upon Matthew Keith Custer's continued service with Cyanotech Corp. on each respective vesting date.
Future Outlook
The equity compensation package for President and CEO Matthew Keith Custer is structured with a three-year vesting schedule, indicating an expectation of his continued leadership and contribution to the company's performance through at least June 2028. The stock options have a ten-year term, aligning long-term incentives for the executive.
Industry Context
Executive equity compensation, such as stock options and restricted stock units, is a standard practice across industries, particularly in publicly traded companies, to attract, retain, and motivate key executives. These grants are designed to align management's financial interests with shareholder value creation over the long term.
Related Party Transactions
- The grant of stock options and restricted stock units to Matthew Keith Custer, the President and CEO, Director, and 10% Owner of Cyanotech Corp., constitutes a related party transaction as it involves compensation from the company to a key executive and insider.
Stakeholder Impact
- Shareholders: Potential future dilution from the vesting and exercise of stock options and RSUs, but also potential benefit from improved executive retention and performance alignment.
- Employees: No direct impact on general employees is mentioned in this filing, but executive compensation practices can indirectly influence overall company culture and compensation philosophy.
Next Steps
- Continued service of Matthew Keith Custer with Cyanotech Corp. to meet vesting conditions for his equity awards.
- Vesting of stock options and restricted stock units on June 16, 2026, June 16, 2027, and June 16, 2028.
- Potential exercise of stock options by their expiration date of June 16, 2035.
Key Dates
| Date | Description |
|---|---|
| 06/16/2025 | Date of grant for 150,000 stock options and 64,103 Restricted Stock Units to Matthew Keith Custer. |
| 06/16/2026 | First vesting date for 50,000 stock options and 21,368 Restricted Stock Units. |
| 06/16/2027 | Second vesting date for 50,000 stock options and 21,368 Restricted Stock Units. |
| 06/16/2028 | Third and final vesting date for 50,000 stock options and 21,367 Restricted Stock Units. |
| 06/18/2025 | Date the Form 4 filing was signed by Laura L. Taylor, by Power of Attorney. |
| 06/16/2035 | Expiration date for the 150,000 stock options. |
Recommendation
holdKeywords
Cyanotech Corp, CYAN, SEC Form 4, Insider Transaction, Executive Compensation, Stock Options, Restricted Stock Units, CEO Grant, Equity Compensation, Matthew Keith Custer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.